These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35313451)

  • 1. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
    McMahan K; Giffin V; Tostanoski LH; Chung B; Siamatu M; Suthar MS; Halfmann P; Kawaoka Y; Piedra-Mora C; Jain N; Ducat S; Kar S; Andersen H; Lewis MG; Martinot AJ; Barouch DH
    Med; 2022 Apr; 3(4):262-268.e4. PubMed ID: 35313451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
    Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
    Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF
    Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.
    Su W; Choy KT; Gu H; Sia SF; Cheng KM; Nizami SIN; Krishnan P; Ng YM; Chang LDJ; Liu Y; Cheng SMS; Peiris M; Poon LLM; Nicholls JM; Yen HL
    J Infect Dis; 2023 May; 227(10):1143-1152. PubMed ID: 35776136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
    Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
    Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
    Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
    Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.
    Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani H; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
    bioRxiv; 2023 May; ():. PubMed ID: 37205409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
    Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
    Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
    Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
    Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
    [No Abstract]   [Full Text] [Related]  

  • 18. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG
    J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
    Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
    Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    Takada K; Orba Y; Kida Y; Wu J; Ono C; Matsuura Y; Nakagawa S; Sawa H; Watanabe T
    J Virol; 2024 May; 98(5):e0178423. PubMed ID: 38624229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.